Chinese hospital M&A review and outlook - 1H 2016

View this page in: 简体中文版

Oct 2016

PwC’s 1H 2016 Chinese Hospital M&A Review and Outlook documents the growth of M&A in China’s healthcare sector over the first half of 2016, benefitting from regulatory reforms and policies promoting investment. According to the review, the total value of M&A deals in healthcare reached RMB14.3 billion by mid-2016.